SCHEMBL30032369

SCHEMBL30032369

CN(C)C(=O)c1ccc(-c2nnc(Br)s2)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ PDK2 Q15119 1/20 0.42
▸ ATR Q13535 1/20 0.40
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CCNE1 P24864 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ MTOR P42345 1/20 0.39
▸ CNR1 P21554 1/20 0.38
▸ SNCA P37840 2/20 0.37
▸ HPN P05981 1/20 0.37
▸ CECR2 Q9BXF3 1/20 0.36
▸ S1PR1 P21453 2/20 0.36
▸ CTSA P10619 1/20 0.36
▸ HPGD P15428 2/20 0.35
▸ NR1H2 P55055 1/20 0.35
▸ NR1H3 Q13133 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ NCOA2 Q15596 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30032460 0.85 KDM4E (0.58) ALDH1A1PDK2ATRMAPTKDM4E
SCHEMBL30032117 0.84 PIK3CA (0.39) ALDH1A1MTORSNCAS1PR1LIPC
Hydrochloric Acid SCHEMBL30032111 0.76 PDK2 (0.35) ALDH1A1PDK2ATRMAPTKDM4E
Hydrochloric Acid SCHEMBL30031488 0.76 GSK3B (0.37) ALDH1A1PDK2ATRKDM4ECCNE1
Hydrochloric Acid SCHEMBL30031687 0.75 S1PR1 (0.41) PDK2ATRCCNE1CDK2MTOR
SCHEMBL4500590 0.73 ALDH1A1 (0.74) ALDH1A1PDK2MAPTKDM4EHPGD
SCHEMBL30032697 0.72 ALDH1A1 (0.51) ALDH1A1PDK2ATRKDM4ECCNE1
SCHEMBL10331346 0.70 PDK2 (0.47) ALDH1A1PDK2ATRMAPTKDM4E
SCHEMBL30031653 0.69 MGAM (0.48) ALDH1A1MAPTKDM4EL3MBTL1MTOR
SCHEMBL9653150 0.69 ALDH1A1 (0.60) ALDH1A1MAPTKDM4EL3MBTL1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363662-A1 COMPOUNDS AS LXR AGONISTS Integral Biosciences Privated Limited (IN) 2022-11-17 — — US disclosed
WO-2022224166-A1 COMPOUNDS AS LXR AGONISTS INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2022-10-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363662-A1 COMPOUNDS AS LXR AGONISTS NR1H2, NR1H3, NR1H4 ALDH1A1 781/4885PDK2 1088/4885ATR 2130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback